Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Treace Medical Concepts, Inc. (TMCI) had Free Cash Flow per Share of $-0.30 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$50.21M |
|
$-16.29M |
|
$10.51M |
|
$39.71M |
|
$65.89M |
|
$-15.68M |
|
$-0.61M |
|
$-16.29M |
|
$-16.29M |
|
$-16.29M |
|
$-16.29M |
|
$-16.29M |
|
$-16.29M |
|
$-15.68M |
|
$-12.83M |
|
63.52M |
|
63.52M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$138.00M |
|
$29.97M |
|
$58.59M |
|
$196.59M |
|
$40.91M |
|
$53.53M |
|
$66.50M |
|
$107.40M |
|
$89.19M |
|
$69.01M |
|
$89.19M |
|
63.70M |
|
| Cash Flow Statement Financials | |
$-7.94M |
|
$3.58M |
|
$0.69M |
|
$11.35M |
|
$7.69M |
|
$-3.66M |
|
$26.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.37 |
|
-- |
|
-- |
|
0.38 |
|
0.60 |
|
79.07% |
|
-31.22% |
|
-31.22% |
|
-- |
|
-32.44% |
|
-32.44% |
|
$-19.06M |
|
-- |
|
-- |
|
-- |
|
0.26 |
|
0.25 |
|
1.52 |
|
59.07 |
|
-18.26% |
|
-23.60% |
|
-8.29% |
|
-11.41% |
|
$1.40 |
|
|
Free Cash Flow per Share |
$-0.30 |
$-0.13 |
|